REDUCED PLATELET MITOGENIC ACTIVITY IN MYELOPROLIFERATIVE DISORDERS
- 9 August 1986
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 328 (8502) , 345
- https://doi.org/10.1016/s0140-6736(86)90034-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Autocrine growth factors and cancerNature, 1985
- Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells.Journal of Clinical Investigation, 1984
- Bleeding and thrombosis in the myeloproliferative disordersBlood, 1984
- Human megakaryocytes. III. Characterization in myeloproliferative disordersBlood, 1984
- Partial purification and characterization of porcine platelet-derived growth factor (PDGF)Experimental Cell Research, 1984
- Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: Relationship to platelet number and functionEuropean Journal of Cancer and Clinical Oncology, 1983
- Human megakaryocyte stimulation of proliferation of bone marrow fibroblastsBlood, 1981